Literature DB >> 35759434

Neurohormonal connections with mitochondria in cardiomyopathy and other diseases.

Gerald W Dorn1.   

Abstract

Neurohormonal signaling and mitochondrial dynamism are seemingly distinct processes that are almost ubiquitous among multicellular organisms. Both of these processes are regulated by GTPases, and disturbances in either can provoke disease. Here, inconspicuous pathophysiological connectivity between neurohormonal signaling and mitochondrial dynamism is reviewed in the context of cardiac and neurological syndromes. For both processes, greater understanding of basic mechanisms has evoked a reversal of conventional pathophysiological concepts. Thus, neurohormonal systems induced in, and previously thought to be critical for, cardiac functioning in heart failure are now pharmaceutically interrupted as modern standard of care. And, mitochondrial abnormalities in neuropathies that were originally attributed to an imbalance between mitochondrial fusion and fission are increasingly recognized as an interruption of axonal mitochondrial transport. The data are presented in a historical context to provide insight into how scientific thought has evolved and to foster an appreciation for how seemingly different areas of investigation can converge. Finally, some theoretical notions are presented to explain how different molecular and functional defects can evoke tissue-specific disease.

Entities:  

Keywords:  angiotensin; cardiomyopathy; epinephrine; mitofusin; neuropathy

Mesh:

Substances:

Year:  2022        PMID: 35759434      PMCID: PMC9363002          DOI: 10.1152/ajpcell.00167.2022

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   5.282


  208 in total

1.  MYOCARDIAL NOREPINEPHRINE CONCENTRATION IN MAN. EFFECTS OF RESERPINE AND OF CONGESTIVE HEART FAILURE.

Authors:  C A CHIDSEY; E BRAUNWALD; A G MORROW; D T MASON
Journal:  N Engl J Med       Date:  1963-09-26       Impact factor: 91.245

Review 2.  MicroRNA and cardiac pathologies.

Authors:  Michael V G Latronico; Daniele Catalucci; Gianluigi Condorelli
Journal:  Physiol Genomics       Date:  2008-06-10       Impact factor: 3.107

3.  Mitofusin2 mutations disrupt axonal mitochondrial positioning and promote axon degeneration.

Authors:  Albert L Misko; Yo Sasaki; Elizabeth Tuck; Jeffrey Milbrandt; Robert H Baloh
Journal:  J Neurosci       Date:  2012-03-21       Impact factor: 6.167

Review 4.  Regulation of mitochondrial bioenergetics by the non-canonical roles of mitochondrial dynamics proteins in the heart.

Authors:  Wang Wang; Celia Fernandez-Sanz; Shey-Shing Sheu
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-09-14       Impact factor: 5.187

5.  MFN2 agonists reverse mitochondrial defects in preclinical models of Charcot-Marie-Tooth disease type 2A.

Authors:  Agostinho G Rocha; Antonietta Franco; Andrzej M Krezel; Jeanne M Rumsey; Justin M Alberti; William C Knight; Nikolaos Biris; Emmanouil Zacharioudakis; James W Janetka; Robert H Baloh; Richard N Kitsis; Daria Mochly-Rosen; R Reid Townsend; Evripidis Gavathiotis; Gerald W Dorn
Journal:  Science       Date:  2018-04-20       Impact factor: 47.728

Review 6.  Mitochondrial permeability transition: a common pathway to necrosis and apoptosis.

Authors:  Jae-Sung Kim; Lihua He; John J Lemasters
Journal:  Biochem Biophys Res Commun       Date:  2003-05-09       Impact factor: 3.575

7.  Molecular screening of 980 cases of suspected hereditary optic neuropathy with a report on 77 novel OPA1 mutations.

Authors:  Marc Ferré; Dominique Bonneau; Dan Milea; Arnaud Chevrollier; Christophe Verny; Hélène Dollfus; Carmen Ayuso; Sabine Defoort; Catherine Vignal; Xavier Zanlonghi; Jean-Francois Charlin; Josseline Kaplan; Sylvie Odent; Christian P Hamel; Vincent Procaccio; Pascal Reynier; Patrizia Amati-Bonneau
Journal:  Hum Mutat       Date:  2009-07       Impact factor: 4.878

8.  Unrestrained erythroblast development in Nix-/- mice reveals a mechanism for apoptotic modulation of erythropoiesis.

Authors:  Abhinav Diwan; Andrew G Koesters; Amy M Odley; Suvarnamala Pushkaran; Christopher P Baines; Benjamin T Spike; Diedre Daria; Anil G Jegga; Hartmut Geiger; Bruce J Aronow; Jeffery D Molkentin; Kay F Macleod; Theodosia A Kalfa; Gerald W Dorn
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-09       Impact factor: 11.205

9.  Loss of Mfn2 results in progressive, retrograde degeneration of dopaminergic neurons in the nigrostriatal circuit.

Authors:  Anh H Pham; Shuxia Meng; Quynh N Chu; David C Chan
Journal:  Hum Mol Genet       Date:  2012-07-31       Impact factor: 6.150

Review 10.  Maturation of Cardiac Energy Metabolism During Perinatal Development.

Authors:  Jérôme Piquereau; Renée Ventura-Clapier
Journal:  Front Physiol       Date:  2018-07-19       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.